UCB's Global Corporate Website

Ginisortamab (UCB6114)

Disease area studied Abbreviated title Phase Study ID Registry database Study results Plain language summary Publication (if available)
Advanced solid tumors A study to assess the safety, pharmacokinetics and anti tumor activity of UCB6114 administered intravenously to participants with advanced solid tumors Phase1/2 ONC001
Sarker D. Cancer Research 2023; 83(8_Supplement) AACR Annual Meeting, April 14-19, 2023, Orlando, USA